LiqTech International priced a $20 million public offering of 20 million shares at $1.00 apiece, with proceeds earmarked to repay $4.1 million in senior notes and accelerate growth in its ceramic filtration markets.
"LiqTech intends to use the net proceeds from the offering to repay approximately $4.1 million of senior notes, invest in business development to accelerate growth in target end markets, fund working capital to support this growth, and fund general corporate activities," the company said in a statement.
The offering includes a 45-day option for underwriter Konik Capital Partners, a division of T.R. Winston & Company, to purchase up to 3 million additional shares to cover over-allotments. The deal is expected to close June 8, subject to customary conditions. The securities are being offered under a Form S-1 registration statement that the Securities and Exchange Commission declared effective June 1.
The capital raise comes as LiqTech, a Danish clean-technology company founded in 2000, seeks to expand its patented Silicon Carbide membrane business across commercial swimming pool, marine water treatment, industrial and municipal water, and oil and gas markets. The 20 million new shares represent a significant increase to the company's outstanding float, diluting existing holders at a time when the stock has traded near $1.00. Ascendiant Capital issued a Buy rating on LiqTech on May 21, according to analyst reports.
LiqTech's Silicon Carbide membranes are designed to treat the most challenging fluids across four end markets. The company's decision to raise equity capital rather than rely solely on operating cash flow to fund growth reflects the capital-intensive nature of scaling advanced filtration manufacturing. With the senior notes repaid, LiqTech will carry reduced debt on its balance sheet, giving it more flexibility to invest in business development and working capital as it pursues market share in the water treatment and oil and gas sectors.
This article is for informational purposes only and does not constitute investment advice.